What question do we want TRACK-HD to answer?
As a comprehensive study of pre-manifest and early HD, TRACK-HD aims to
measure the sensitivity of individual and combined assessment tools to
detect subtle changes in disease progression. The ultimate goal is to
establish what combination of measures is the most sensitive for
detecting change over the natural course of HD. This would lay the
foundations to develop the much-needed methodology to undertake future
clinical trials of disease-modifying agents in HD.